On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

John Vissing

ResearcherPublications, citations & collaboration network

John Vissing is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does John Vissing have?

ScholarIQindexed works

John Vissing has 878 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does John Vissing have?

ScholarIQcitation count

John Vissing has 20,113 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of John Vissing?

ScholarIQh-index

John Vissing has an h-index of 72 in OpenAlex.

What is the i10-index of John Vissing?

ScholarIQi10-index

John Vissing has an i10-index of 350 in OpenAlex.

What is the ORCID of John Vissing?

ScholarIQorcid

The ORCID for John Vissing is on the source record.

What is the OpenAlex record for John Vissing?

ScholarIQopenalex

The OpenAlex for John Vissing is on the source record.

What are the most-cited papers on John Vissing?

ScholarIQmost cited works
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
James F. Howard, Kimiaki Utsugisawa, Michael Benatar, Hiroyuki Murai, Richard J. Barohn, Isabel Illa, Saiju Jacob, John Vissing, Ted M. Burns, John T. Kissel, Srikanth Muppidi, Richard J. Nowak, Fanny O’Brien, Jingjing Wang, Renato Mantegazza, Claudio Mazia, Miguel Wilken, Carolina Ortea, Juliet Saba, Marcelo Rugiero, Mariela Bettini, Gonzalo Vidal, Alejandra Dalila Garcia, Phillipa J. Lamont, Wai-Kuen Leong, Heidi Boterhoven, Beverly Fyfe, L. Jackson Roberts, Mahi Jasinarachchi, Natasha Willlems, Julia Wanschitz, Wolfgang N. Löscher, Jan De Bleecker, Guy Van den Abeele, Kathy de Koning, Katrien De Mey, Rudy Mercelis, Linda Wagemaekers, Délphine Mahieu, Philip Van Damme, Charlotte Smetcoren, Olivier Stevens, Sarah Verjans, Ann D’Hondt, Petra Tilkin, Alzira Alves de Siqueira Carvalho, Rosa Hasan, Igor Dias Brockhausen, David Feder, Daniel Ambrosio, Ana Paula Souto Melo, Rosana Rocha, Bruno Bezerra Rosa, Thabata Veiga, Luiz Augusto da Silva, Jordana Gonçalves Geraldo, Maria da Penha Morita Ananias, Érica Nogueira Coelho, Gabriel Pina Paiva, M Tovar Pozo, Natália Prando, Debora Dada Martineli Torres, Cristiani Fernanda Butinhao, Érica Nogueira Coelho, Luciana Renata Cubas Volpe, Gustavo Duran, Tamires Cristina Gomes da Silva, Luiz Otavio Maia Gonçalves, Lucas Eduardo Pazetto, Luciana Souza Duca, Tomás Augusto Suriane Fialho, Maurício Friedrich, Alexandre Guerreiro, Henrique Mohr, Maurer Pereira Martins, Daiane da Cruz Pacheco, Ana Paula Macagnan, Aline de Cassia Santos, Acary Souza Bullé Oliveira, Ana Carolina Amaral de Andrade, Marcelo Annes, Valéria Cavalcante Lino, Wladimir Bocca Vieira de Rezende Pinto, Carolina Miranda, Fernanda Carrara, Iandra Souza, Angela Genge, Rami Massie, Natasha Campbell, Vera Bril, Hans Katzberg, Mehran Soltani, Eduardo Ng, Zaeem A. Siddiqi, Celile Phan, Derrick Blackmore, Stanislav Voháňka, Josef Bednařík, Magda Chmelikova, Marek Čierny
The Lancet Neurology. 2017816 Citations
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
James F. Howard, Vera Bril, Tuan Vu, Chafic Karam, Stojan Perić, Temur Margania, Hiroyuki Murai, Małgorzata Bilińska, R Shakarishvili, Marek Śmiłowski, Antonio Guglietta, Peter Ulrichts, Tony Vangeneugden, Kimiaki Utsugisawa, Jan J.G.M. Verschuuren, Renato Mantegazza, Jan L. De Bleecker, Kathy de Koning, Katrien De Mey, Annelien De Pue, R. Mercelis, Maren Wyckmans, Caroline Vinck, Linda Wagemaekers, Jonathan Baets, Eduardo Ng, Jafar Shabanpour, Lubna Daniyal, Shabber Mannan, Hans Katzberg, Angela Genge, Zaeem A. Siddiqi, Jana Junkerová, Jana Hořáková, Katerina Reguliova, Michaela Týblová, Ivana Jurajdova, Iveta Nováková, Michala Jakubíková, Jiří Piťha, Stanislav Voháňka, Katerina Havelkova, Tomáš Horák, Josef Bednařík, Mageda Horakova, Andreas Meisel, Dike Remstedt, Claudia Heibutzki, Siegfried Köhler, Lea Gerischer, Sarah Hoffman, Frauke Stascheit, John Vissing, Lizzie Zafirakos, Kuldeep Kumar Khatri, Anne Ostergaard Autzen, Mads Stemmerik, Henning Andersen, Shahram Attarian, Emmanuelle Salort‐Campana, Émilien Delmont, Aude‐Marie Grapperon, Ludivine Kouton, Alexander Tsiskaridze, Csilla Rózsa, Gedeonne Jakab, Szilvia Z. Tóth, G Szabó, David Bors, Enikő Szabó, Angela Campanella, Fiammetta Vanoli, Rita Frangiamore, Carlo Antozzi, Silvia Bonanno, Lorenzo Maggi, Riccardo Giossi, Francesco Saccà, Angela Marsili, Chiara Pane, Giorgia Puorro, Antonio Reia, Giovanni Antonini, Girolamo Alfieri, Stefania Morino, Matteo Garibaldi, Laura Fionda, Luca Leonardi, Shingo Konno, Akiyuki Uzawa, Kaoru Sakuma, Chiho Watanabe, Yukiko Ozawa, Manato Yasuda, Yosuke Onishi, Makoto Samukawa, Tomoko Tsuda, Yasushi Suzuki, Sayaka Ishida, Genya Watanabe
The Lancet Neurology. 2021692 CitationsOPEN ACCESS
Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis
Srikanth Muppidi, Kimiaki Utsugisawa, Michael Benatar, Hiroyuki Murai, Richard J. Barohn, Isabel Illa, Saiju Jacob, John Vissing, Ted M. Burns, John T. Kissel, Richard J. Nowak, Henning Andersen, Carlos Casasnovas, Jan L. De Bleecker, Tuan Vu, Renato Mantegazza, Fanny O’Brien, Jing Jing Wang, Kenji P. Fujita, James F. Howard, for the Regain Study Group
Muscle & Nerve. 2019253 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account